Trade Bristol Myers BMY

BristolMyers live chart

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

BristolMyers News

Sophia Claire 2025 Aug 08, 10:10

Trump's Tariff Threat on Russian Oil: A Risky Gamble for Energy Markets

Noah Lee 2025 Aug 08, 04:10

Stephen Miran's Fed Nomination: An Analysis of Potential Impacts

Liam James 2025 Aug 08, 03:10

OpenAI Unveils GPT-5: Major Upgrades and New Features for Free and Paid Users

Ghko B 2025 Aug 07, 16:00

Fortinet stock collapsed: Why Fortinet Stock (FTNT) Is Down Today?

stocks
Ghko B 2025 Aug 07, 16:00

CFD Indices Trading Guide: US100 index CFD, DE30 index CFD. Nikkei CFD

indices cfd trading
Ghko B 2025 Aug 07, 16:00

CFD Currency Pairs Trading Guide: How to Trade Forex with CFDs?

forex
Magnificent 7 earnings, US and Japan inflation due next week
Neil Wilson 2024 Jul 18, 16:00

Week ahead: Magnificent 7 earnings, 2 key inflation reports

Forex Indices
Wall Street earnings
Neil Wilson 2023 Oct 20, 10:00

Week ahead: Earnings bonanza, ECB decision & US inflation

Forex Indices
Megacap-tech-stocks.jpg
Neil Wilson 2023 Apr 21, 05:00

Week ahead: Megacap tech and 1-in-3 Dow components set to report

2022 Jul 24, 05:42

Week ahead: Fed to hike 100bps into a recession?

Latest news

Show more
Tommy Yap 2025 Aug 09, 21:00

Week Ahead: RBA interest rate decision and US CPI data in focus

Forex Indices
Sophia Claire 2025 Aug 09, 02:20

Market Review: Gold, Oil, Geopolitics & Tariffs - A Comprehensive Overview

Ava Grace 2025 Aug 08, 15:20

Bitcoin Cycle Shift: A Look at the New Era of Institutional Dynamics & Regulation

Emma Rose 2025 Aug 08, 15:20

US and Russia Negotiating Ukraine Peace Deal: Will Conflict Be Frozen?

Noah Lee 2025 Aug 08, 13:20

Gold Futures Soar Amid Tariff Concerns: A Comprehensive Analysis

Emma Rose 2025 Aug 08, 10:20

Oil Price Stabilization: Impact of US Sanctions & Geopolitical Tensions

Ava Grace 2025 Aug 08, 08:20

Economists Warn Trump's BLS Firing Parallels Authoritarian Leaders

Ava Grace 2025 Aug 08, 06:05

Cambodia Nominates Trump for Nobel Peace Prize Over Thailand Border Conflict

Info

Spread

0.29

Spread (%)

0.6326 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Monday

13:31 - 19:59

Tuesday

13:31-19:59

Wednesday

13:31-19:59

Thursday

13:31-19:59

Friday

13:31-19:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

93528473600

Shares Outstanding

2035440000

Earnings Date (Next)

2001-08-07

Div Yield

2025-08-01

Ex-Dividend Date

2025-07-03

Forward annual dividend rate

2.48

Forward annual dividend yield

0.054

EPS

2.49

Learn more about this instrument

Bristol Myers Bristol-Myers Squibb Company
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE; Opdivo for various anti-cancer indications; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel to treat patients with Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of relapsed/refractory multiple myeloma; Abecma for the treatment of patients with relapsed or refractory multiple myeloma; Reblozyl to treat anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of patients with relapsed or refractory large B-cell lymphoma; Cobenfy to treat schizophrenia in adults; Krazati for the treatment of adult patients with KRASG12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC); Camzyos to treat symptomatic obstructive HCM to improve functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug to treat multiple myeloma; and Abraxane for the treatment of breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.

Related Instruments

Asset
Sell
Buy
Change (%)
View all instruments

Latest Education Articles

Show more
Frances Wang 2025 Aug 07, 16:00

What is CFD trading: Understanding Risks and Considerations for CFD Trading

CFD Trading
Frances Wang 2025 Aug 07, 16:00

CFD Trading Explained For Beginners: What Are CFDs?

CFD Trading
Ghko B 2025 Aug 06, 16:00

CFD Trading for Beginners: MetaTrader 4 vs MetaTrader 5

Stocks
Trustpilot